|1.||Wang, Keli: 1 article (01/2014)|
|2.||Zhao, Ziming: 1 article (01/2014)|
|3.||Song, Yuanjian: 1 article (01/2014)|
|4.||Han, Jin: 1 article (01/2014)|
|5.||Yin, Xiaoxing: 1 article (01/2014)|
|6.||Yang, Dan: 1 article (01/2014)|
|7.||Wang, Yu: 1 article (01/2014)|
|8.||Du, Qian: 1 article (01/2014)|
|9.||Yang, Yihua: 1 article (01/2014)|
|10.||Evang, J Arild: 1 article (08/2010)|
09/01/2001 - "No tumor-specific mutation was detected, but polymorphisms were identified in E2F-1 exon 5 and in the polyserine tract of E2F-4. "
01/01/2014 - "As a novel hydrophilic segment, poly(L-serine) was utilized to enhance tumor targeting due to a large demand of tumors for serine. "
01/01/2014 - "Self-assembled micelles of amphiphilic poly(L-phenylalanine)-b-poly(L-serine) polypeptides for tumor-targeted delivery."
|3.||Huntington Disease (Huntington's Disease)
11/01/2006 - "We have shown both +1 frameshift and +2 frameshift products (which may contain polyalanine or polyserine tracts, respectively) in human postmortem Huntington's disease brains and in a transgenic mouse model of Huntington's disease. "
11/01/2006 - "Polyalanine and polyserine frameshift products in Huntington's disease."
11/01/2006 - "This may be relevant to the pathogenesis of human Huntington's disease, as we have previously shown that both polyserine and polyalanine-containing proteins are modifiers of mutant huntingtin toxicity, with low expression levels of polyalanine-containing proteins having a protective effect."
|2.||Proteins (Proteins, Gene)